Safety, tolerability, and immunogenicity of a 31-valent pneumococcal conjugate vaccine (VAX-31) in healthy adults aged 50 years and older from the USA: a phase 1/2, double-blinded, active-controlled, parallel-group, dose-finding randomised clinical trial. (linkinghub.elsevier.com)

Authors: Wassil J … Sisti M Journal: Lancet Infectious Diseases Published: 2026-03-18 DOI: https://doi.org/10.1016/S1473-3099(26)00059-9